RFK Jr.'s Controversial HHS Moves: Shaking Up Health Policy and Eyeing 2028

Robert F. Kennedy Jr. BioSnap a weekly updated Biography. Robert F. Kennedy Jr. has been the center of a political and scientific storm over the past week, making headlines with moves that some see as long-term game changers in government, public health, and perhaps even in his own ambitions. According to Axios, there is already growing buzz about Kennedy possibly mounting another White House run in 2028. While an explicit campaign announcement was notably absent, his supporters are mobilizing. His MAHA PAC, born from last year’s American Values 2024 effort, held a high-energy organizing call with hundreds of supporters, influencers like Russell Brand and Tony Robbins, and key advisers, stoking speculation that the infrastructure for a future campaign is quietly being built behind the scenes. As Health and Human Services Secretary in the Trump administration, Kennedy has had a jam-packed week of controversy and high-drama decision-making. ABC News reports he abruptly fired both his chief of staff and chief deputy for policy, replacing them with Matt Buckham, his White House liaison. The agency offered no official reason, but this shake-up sent shockwaves through HHS. Kennedy is also flexing his authority over federal health programs, as detailed by HealthDay and The New York Times. He cancelled last week’s meeting of the U.S. Preventive Services Task Force without warning, raising concerns among doctors and researchers who rely on the panel to set science-based insurance coverage standards for preventive medicine. This move has health experts and organizations, including AcademyHealth and over a hundred health groups, sounding alarms about political interference. Policy changes are also moving at warp speed under his leadership. As ProPublica documents, Kennedy is taking aim at the Vaccine Injury Compensation Program, a cornerstone of America’s childhood immunization system. He’s brought in Andrew Downing, a well-known vaccine injury lawyer, to overhaul the program, sparking concern among experts who fear destabilization of vaccine access and safety nets for families with rare adverse reactions. Within days, Senator Ron Wyden called out Kennedy, stating in an official release that his agenda is delivering a “devastating blow to new cures,” referencing new data that concludes Kennedy’s policies may sharply reduce drug innovation and future treatments. On a different note, Kennedy’s public push for psychedelic therapy made national news through the Associated Press, when he pledged to clear a path for clinical psychedelic treatments within a year, surprising even supporters of the drugs. Social media has been abuzz with hashtags like #MAHA and #RFKJr, amplifying every move, particularly as the aftermath of last year’s historic third-party run in which Kennedy received massive grassroots support—though, according to multiple analysts, his campaign ended up aiding Donald Trump’s victory. All told, this week has solidified RFK Jr.’s place as a